Dr. Tracy Lynn Chason, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1007 Greenfield Drive, Tifton, GA 31794 Phone: 229-392-9733 |
Timothy Fuller, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1641 Madison Ave, Tifton, GA 31794 Phone: 229-353-2284 |
Forte David Mceachin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1007 Greenfield Dr, Tifton, GA 31794 Phone: 229-382-9733 Fax: 229-387-6161 |
William H Davis, MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 1007 Greenfield Dr, Tifton, GA 31794 Phone: 229-382-9733 Fax: 229-387-6161 |
Joel M Johnson, MD Surgery Medicare: Medicare Enrolled Practice Location: 1007 Greenfield Drive, Tifton, GA 31794 Phone: 229-382-9733 Fax: 229-387-6161 |
Dr. William Leslie Hornback Iv, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1007 Greenfield Dr, Tifton, GA 31794 Phone: 229-382-9733 |
Dr. Paul Thomas Cartwright, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1007 Greenfield Dr, Tifton, GA 31794 Phone: 229-382-9733 |
News Archive
A group of artists, young people and medical experts are involved in a groundbreaking project at The Children's Hospital of Philadelphia that uses the intimate process of portrait painting to help children and young people with craniofacial problems see themselves in a different light.
1-800-DENTIST® has recently launched My Smile Bites, a nationwide $30,000 cosmetic dentistry makeover contest for anyone whose smile has impacted their lives negatively. As of today over 230 contestants have uploaded their personal two-minute videos, sharing their own stories about how their teeth affect the way they feel and interact with people.
UNICEF on Thursday launched a $1.2 billion appeal aimed at providing "life saving emergency assistance to millions of children and women in dire need," VOA News reports (Schlein, 2/4). "The appeal is part of UNICEF's Humanitarian Action Report 2010, released in Geneva ... which spotlights the desperate situation of children and women in 28 countries and territories facing deep humanitarian crises," the U.N. News Centre writes (2/4).
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
Biologists have developed an efficient way to genetically modify human embryonic stem cells. Their approach, which uses bacterial artificial chromosomes to swap in defective copies of genes, will make possible the rapid development of stem cell lines that can both serve as models for human genetic diseases and as testbeds on which to screen potential treatments, they say.
› Verified 7 days ago